Bruker Corporation
Bruker Corporation
- Market cap
- $8.65B
Your view on BRKRP
Overview
What the company does, where it operates, and who runs it.
About Bruker Corporation
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Frank H. Laukien
- Headquarters
- 40 Manning Road, Billerica, MA, US
- Industry
- Medical - Devices
- Sector
- Healthcare
- CEO
- Frank H. Laukien
- Headquarters
- 40 Manning Road, Billerica, MA, US
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies.
The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions.
It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment.
In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation.
Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
Stock Data
Price chart, volume, and trading data.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Bruker Corporation. Starting points for Bruker Corporation: EPS -$0.81, beta 1.39 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Bruker Corporation. Bruker Corporation paid $15.94 per share over the last year — a 3.9% yield at the current $411.77 price. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Bruker Corporation. Trailing twelve-month EPS for Bruker Corporation stands at -$0.81. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Bruker Corporation. Bruker Corporation has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
| Ticker | Type | Company | Sector | Exchange | Mkt cap |
|---|---|---|---|---|---|
| MTLZFMetall Zug AG | Healthcare | OTC | $686.6M | ||
| MX1.AXMicro-X Limited | Healthcare | ASX | — | ||
| MYOMyomo, Inc. | Healthcare | AMEX | $32.5M | ||
| NEOGNeogen Corporation | Healthcare | NASDAQ | $2.3B | ||
| NGMDFNuGen Medical Devices Inc. | Healthcare | OTC | $5.9M | ||
| NHNKFNihon Kohden Corporation | Healthcare | OTC | $2.4B | ||
| NHNKYNihon Kohden Corporation | Healthcare | OTC | $3.7B | ||
| NMRDNemaura Medical Inc. | Healthcare | OTC | $404 | ||
| NMTCNeuroOne Medical Technologies Corporation | Healthcare | NASDAQ | $5.9M | ||
| NNOXNano-X Imaging Ltd. | Healthcare | NASDAQ | $17.7M | ||
| NPCENeuroPace, Inc. | Healthcare | NASDAQ | $273.9M | ||
| NSPRInspireMD, Inc. | Healthcare | NASDAQ | $25.1M | ||
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Bruker Corporation executives and directors. Shares of Bruker Corporation have traded between $250.00 and $474.99 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Bruker Corporation. Coverage tracks Bruker Corporation within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Bruker Corporation.